πŸ‡ΊπŸ‡Έ FDA
Patent

US 6632809

Gyrase inhibitors and uses thereof

expired A61KA61K31/00A61K31/4184

Quick answer

US patent 6632809 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/00, A61K31/4184, A61K31/423, A61K31/437